CAPE CLL Initiative


Overview of CAPE

The Cancer Advocacy & Patient Education (CAPE) initiative aims to create a web-based library of best-practice information that providers in the CLL cancer space can give to their patients and caregivers at each point of interaction. This program is supported by funding from Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.

Our Mission

To improve patient experience from cancer diagnosis through the cancer trajectory with personalized education

Our Vision

Engage, inform, and empower newly diagnosed cancer patients utilizing a predetermined quality-of-life model to reduce distress and improve patient experience from diagnosis through the cancer trajectory.

Related Links

Navigating Chronic Lymphocytic Leukemia (CLL): The Critical Importance of the First 90 Days

Navigating Chronic Lymphocytic Leukemia: The Critical Importance of the First 90 Days. Navigation Strategies to Improve Care

Chronic Lymphocytic Leukemia (CLL) Publications for Patients, Caregivers, Healthcare Providers

Physical, Psychological, Social, and Spiritual Well-Being of Patients with Chronic Lymphocytic Leukemia and Their Caregivers: A Scoping Review


    CAPE CLL Videos